Balaji Amines rises 19% on HUG
balaji amines share price
Share price of Balaji Amines hit a 52-week high of ₹2,062.50, up 19 per cent on the BSE in intra-day trade on Tuesday amid heavy volumes.
The share price of the specialty chemicals company surpassed its previous high of ₹1,956.80 touched on May 25, 2026. It reached a record high of ₹5,220 on September 15, 2021.
The market value of Balaji Amines has increased by 54 percent in the last three weeks. Moreover, the stock has surged 128 per cent compared to a nearly 7 per cent fall in the BSE Sensex in the last three months.
02:01 pm; Balaji Amines was quoting 17 per cent higher at ₹2,027.50 on the BSE. The average trading volume on the counter surged more than six times, with a combined 2.25 million shares exchanged hands on the NSE and BSE.
Watch Stock Market Latest Updates Live Today
Balaji Amines Overview, Q4 Results
Balaji Amines is a leading manufacturer of Aliphatic Amines in India. Broadly, the company specializes in manufacturing of Methyl Amine, Ethyl Amine, Derivatives of Aliphatic Amine and Specialty Chemicals. Its business is broadly classified into three segments – Amines, Specialty Chemicals and Derivatives.
The company has a leading position in many of its products such as Monomethylamine (MMA), Dimethyl Amine (DMA), Trimethylamine (TMA), Dimethyl Amino Ethanol (DMAE), Mono Methyl Amino Ethanol etc. It caters to many industries like pharma, agro chemicals, paint stripping and resins, rubber cleaning chemicals etc.
For the quarter and year ended March 31, 2026, Balaji Amines demonstrated resilience in its operating performance despite temporary external disruption during the month of March 2026. Production was briefly affected due to the geopolitical situation; However, the company was able to minimize the impact through prudent inventory planning and uninterrupted availability of raw materials.
Revenue from operations stood at ₹403 crore in Q4FY26, compared to ₹361 crore in Q3FY26, indicating a stable operating performance of around 12 per cent. Sales volumes remained at the same level as the previous period. Balaji Amines said the increase in revenue was due to rising commodity prices and consistent demand across key sectors.
Read | Sensex rises 1,000 points from day’s low; Nifty above 23,550; main reason
EBITDA margin increased to 25 per cent in Q4FY26, compared to 18 per cent in Q3FY26 and 19 per cent in Q4FY25. Margin improvement was primarily supported by improved operating leverage, stable raw material position, prudent inventory planning, improved cost efficiency and favorable product mix. The company’s profit after tax more than doubled to ₹65 crore compared to ₹31 crore in Q3FY26.
The performance during the quarter was supported by stable demand in key segments, improved operational performance, better cost absorption and continued contribution of integrated manufacturing model.
The company said that due to a flexible business plan and growing specialty chemicals portfolio and emerging export opportunities, Balaji Amines is well positioned for sequential growth in operations during this period.
Commissioning of DME, N-Methyl Morpholine (NMM), Acetonitrile and expansion projects of Balaji Specialty Chemicals will be important milestones in the coming quarters. While management said they keep an eye on raw material prices, global demand conditions and geopolitical developments, they believe Balaji Amines is well positioned for sequential growth.
